Colon cancer can cause kidney failure through several distinct pathways, some related to the tumor itself and others to the treatments used against it. The connection is not as widely recognized as kidney damage from, say, bladder or prostate cancers, but it is well documented. Roughly one in five patients develops some degree of acute kidney injury around the time of colorectal cancer surgery alone, and that is only one piece of the picture. The relationship between colon cancer and kidney problems turns out to be surprisingly multifaceted.
When the Tumor Itself Blocks the Kidneys
The most direct way colon cancer causes kidney failure is physical obstruction. Your kidneys drain urine through two narrow tubes called ureters that run down behind the colon and into the bladder. A large or advanced colorectal tumor can press on or invade one or both ureters, blocking urine flow. When urine backs up into the kidneys, they swell and stop filtering properly. This is called obstructive kidney injury, and while it is more commonly associated with cancers of the bladder, prostate, or cervix, colorectal cancer can do it too.1PubMed Central. An Unusual Case of Bilateral Ureteric Obstruction Caused by Colorectal Cancer If only one ureter is blocked, the other kidney can compensate and you might not notice symptoms right away. When both sides are blocked, kidney function can deteriorate rapidly.
Case reports describe patients whose first sign of colorectal cancer relapse was worsening kidney function. In one documented case, a patient presented with acute kidney injury and was found to have new bilateral obstruction of both ureters from a colorectal cancer recurrence, requiring intensive care admission.1PubMed Central. An Unusual Case of Bilateral Ureteric Obstruction Caused by Colorectal Cancer Treatment usually involves placing a stent or drainage tube to relieve the blockage, but the underlying cancer needs to be addressed for the problem to resolve long-term.
Metastasis to the Kidneys
Colon cancer spreading directly to the kidney is genuinely rare. The liver and lungs are the most common destinations for colorectal metastases, and kidney involvement is unusual enough that individual cases still get published as noteworthy reports. One case described a patient who developed a metastatic deposit in the left kidney four years after initial colorectal cancer treatment, requiring removal of the kidney.2PubMed Central. Sigmoid adenocarcinoma with metastases to the kidney: Report of a rare case and review of the literature Another involved a patient found to have colon cancer and a kidney metastasis simultaneously at the time of first diagnosis.3PubMed. Colon cancer with isolated metastasis to the kidney at the time of initial diagnosis
When colorectal cancer does reach the kidney, it tends to form a distinct mass in the kidney tissue rather than diffusely infiltrating it. One case report noted that while implantation of colon cancer cells in the lining of the renal pelvis has been described, actual metastasis into the kidney tissue itself is extremely rare.4PubMed Central. Complex pattern of colon cancer recurrence including a kidney metastasis: a case report The practical implication is that if you have colorectal cancer and a new kidney mass is found, it is statistically more likely to be a separate primary kidney cancer than a metastasis from the colon. But the possibility exists and imaging alone cannot always tell the difference.
Kidney Injury from Colorectal Cancer Surgery
Surgery to remove a colorectal tumor is one of the more common triggers for kidney problems in this patient population. A large population-based study found that about one in five patients developed acute kidney injury within a week of colorectal cancer surgery.5PubMed. Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study Most cases were mild, but roughly three percent reached the most severe stage. A meta-analysis pooling data from over 167,000 patients identified several risk factors that make postoperative kidney injury more likely: being male, older age, being overweight, having high blood pressure or diabetes, pre-existing kidney disease, emergency surgery, open rather than minimally invasive procedures, longer operations, and needing a blood transfusion during surgery.6PubMed Central. Risk factors for postoperative acute kidney injury in colorectal cancer: a systematic review and meta-analysis
A separate and underappreciated risk comes after surgery, when a temporary ileostomy is created. An ileostomy diverts the bowel contents to an external bag, allowing a surgical connection further downstream to heal. The problem is that the small intestine absorbs a lot of water, and bypassing the colon means the body loses far more fluid than usual. High-output ileostomies can lead to dehydration severe enough to cause kidney injury.7PubMed. Readmission with acute kidney injury following ileostomy: patterns and predictors of a common phenomenon In one study, patients with an ileostomy were roughly ten times more likely to be readmitted with kidney injury than those without one, and were about four times more likely to develop significant chronic kidney disease within a year.8PubMed. Ileostomy creation in colorectal cancer surgery: risk of acute kidney injury and chronic kidney disease Staying well hydrated and monitoring kidney function closely after ileostomy creation makes a real difference here.
Chemotherapy Drugs That Harm the Kidneys
Several drugs commonly used to treat colorectal cancer can damage the kidneys. The mechanisms differ depending on the drug, but the end result is the same: reduced kidney function that may require dose adjustments, treatment pauses, or even permanent discontinuation of the drug.
Oxaliplatin, a platinum-based drug central to many colorectal cancer regimens, can cause direct damage to the kidney’s filtering tubes. This type of injury, called acute tubular necrosis, is rare but serious. Documented cases show that patients’ kidney function typically recovers, but the episode can be dramatic enough to require temporary dialysis.9PubMed Central. Severe acute tubular necrosis observed subsequent to oxaliplatin administration
Bevacizumab, a targeted drug that blocks the growth of new blood vessels feeding a tumor, carries a different kidney risk. It can cause the kidneys to leak protein into the urine, a condition called proteinuria. A meta-analysis found that adding bevacizumab to standard chemotherapy nearly quintupled the risk of severe proteinuria compared to chemotherapy alone and increased the risk of full-blown nephrotic syndrome almost eightfold.10PubMed Central. Bevacizumab increases risk for severe proteinuria in cancer patients Kidney biopsies from patients treated with bevacizumab show a distinctive pattern of damage to the tiny blood vessels inside the kidney.11Modern Pathology. Bevacizumab-associated glomerular microangiopathy Higher doses carry a greater risk. Urine is typically monitored throughout treatment for this reason.
Capecitabine, an oral chemotherapy pill used in many colorectal cancer regimens, has also been shown to cause kidney toxicity, though severe cases in humans appear less common than with the drugs above. Animal studies confirm that capecitabine exposure produces elevated markers of kidney injury along with visible tissue damage.12PubMed. The effect of melatonin on capecitabine-induced hepatic and renal toxicity in rats When kidney function starts declining during chemotherapy, oncologists face a tricky balancing act: reducing drug doses protects the kidneys but may compromise cancer treatment.13PubMed Central. Chronic Kidney Disease Prevalence in Patients with Colorectal Cancer Undergoing Surgery
Paraneoplastic Kidney Disease and Tumor Lysis Syndrome
Sometimes the cancer damages the kidneys without physically touching them, through substances the tumor releases into the bloodstream. These are called paraneoplastic effects, and they represent some of the more surprising ways colon cancer can lead to kidney failure.
One documented pattern involves the immune system reacting to the tumor in a way that also attacks the kidneys’ filtering units. Membranous nephropathy and membranoproliferative glomerulonephritis are both forms of kidney inflammation that have been reported alongside colorectal cancer.14PubMed Central. Nephrotic syndrome as a possible indicator of colonic cancer: A case report 15PubMed Central. An association between membranoproliferative glomerulonephritis and metastatic colorectal carcinoma: a case report In these cases, treating the cancer itself is the primary approach to resolving the kidney disease. Occasionally, new-onset nephrotic syndrome turns out to be the first clue that an underlying cancer exists.
Hypercalcemia, or dangerously high blood calcium, is another route. Some colorectal cancers produce a hormone-like protein that forces calcium out of bones and into the blood. A review of published cases found that this was most common in patients with advanced, metastatic disease, particularly those with liver metastases. The calcium levels in these patients tended to be severely elevated, and the condition carried very high mortality with a median survival measured in weeks rather than months.16PubMed Central. Hypercalcemia of Malignancy and Colorectal Cancer High calcium damages the kidneys both by constricting blood vessels within them and by promoting calcium deposits in kidney tissue.
Tumor lysis syndrome represents perhaps the most acute threat. When a large volume of cancer cells die suddenly, often after starting chemotherapy, they dump their internal contents into the bloodstream. This floods the body with uric acid, phosphorus, and potassium. A systematic review of tumor lysis syndrome in colorectal cancer found that kidney injury was present in every patient with available data, and nearly all had stage IV disease.17Journal of Clinical Oncology. Tumor lysis syndrome in colorectal cancer: A systematic review of clinical characteristics While tumor lysis syndrome is more commonly associated with blood cancers, it does occur with solid tumors that have a large tumor burden or are particularly responsive to treatment.
Kidney Risks from Diagnostic Procedures
Even the process of diagnosing and monitoring colorectal cancer can put the kidneys at risk. Two diagnostic-related hazards deserve attention: the contrast dye used in CT scans and the bowel preparation solutions used before colonoscopy.
CT scans with iodinated contrast are a routine part of colorectal cancer staging and surveillance. A study of cancer inpatients found that contrast dye increased the risk of a kidney event by about 0.8 percentage points above the baseline risk from the CT scan itself.18PubMed Central. Risk of renal events following intravenous iodinated contrast material administration among inpatients admitted with cancer a retrospective hospital claims analysis That might sound small, but the risk climbed steeply in patients who already had reduced kidney function. A separate study looking at high-risk cancer patients found that about 4 percent developed presumed contrast-related kidney injury, though none required dialysis or had permanent damage.19PLOS ONE. Incidence of contrast-induced acute kidney injury (CI-AKI) in high-risk oncology patients undergoing contrast-enhanced CT with a reduced dose of the iso-osmolar iodinated contrast medium iodixanol
The bowel preparation used before colonoscopy poses a more insidious risk. Oral sodium phosphate solutions, once widely used as bowel cleaners, can cause a condition called acute phosphate nephropathy. The phosphate gets absorbed into the blood, and when it reaches high enough concentrations, calcium phosphate crystals deposit in the kidney’s tubes and cause lasting damage. A landmark biopsy study identified 21 cases of this injury at a single institution over a four-year period, all in patients who were otherwise healthy enough that hypercalcemia was ruled out as a cause.20PubMed. Acute phosphate nephropathy following oral sodium phosphate bowel purgative: an underrecognized cause of chronic renal failure Risk factors include dehydration (common during bowel prep), older age, and the use of certain blood pressure medications like ACE inhibitors or diuretics.21PubMed. Renal failure due to acute nephrocalcinosis following oral sodium phosphate bowel cleansing This is one reason many gastroenterologists have shifted toward polyethylene glycol-based preps, which do not carry the same phosphate risk.
Immune Checkpoint Inhibitors and the Kidneys
Immunotherapy drugs called checkpoint inhibitors are increasingly used for a subset of colorectal cancers, specifically those with a molecular feature called microsatellite instability. These drugs work by removing the brakes from the immune system so it can attack the cancer more aggressively. The tradeoff is that the unleashed immune system sometimes attacks healthy tissue, including the kidneys. Checkpoint inhibitor-associated kidney injury occurs in roughly 2 to 5 percent of treated patients and most commonly shows up as inflammation of the kidney’s tubes and surrounding tissue.22Nature Reviews Nephrology. Diagnosis and management of immune checkpoint inhibitor-associated acute kidney injury The encouraging news is that this type of kidney injury generally responds well to steroids if caught early.
A more unusual complication involves a protein called amyloid A. Case reports have described patients on checkpoint inhibitors for colon cancer and other cancers who developed amyloid A deposits in their kidneys. In these cases, the cancers were actually in remission, yet the ongoing immune activation from the drug drove persistent inflammation that led to amyloid buildup.23Journal of Onco-Nephrology. Immune checkpoint inhibitor–associated renal amyloid A amyloidosis: A case series and review of the literature This is a rare scenario, but it highlights how immune-modulating cancer treatments can affect the kidneys through unexpected mechanisms.
Dehydration as a Hidden Driver
A less dramatic but very common pathway to kidney trouble in colon cancer patients is simple dehydration. Advanced colorectal tumors, especially large villous adenomas, can secrete enormous amounts of mucus and cause chronic, watery diarrhea. One case report described an elderly patient whose large colonic tumor caused such severe diarrhea that he became profoundly dehydrated, leading to acute kidney failure on top of his existing chronic kidney disease.24PubMed Central. Prerenal uremia induced by severe diarrhea due to colon adenoma: a case of McKittrick-Wheelock syndrome in an elderly patient This kind of kidney injury is called prerenal because the kidneys themselves are not damaged — they simply are not getting enough blood flow due to low fluid volume. It is reversible with rehydration, but if unrecognized, it can progress to true kidney damage.
Diarrhea from chemotherapy, radiation to the pelvis, or the cancer itself all contribute to fluid loss. Nausea and vomiting reduce fluid intake. Older patients are already less able to compensate for fluid shifts. The cumulative effect is that kidney function in colorectal cancer patients deserves ongoing monitoring even outside the immediate postoperative or chemotherapy windows.
The Reverse Connection Between Chronic Kidney Disease and Colorectal Cancer
The relationship between kidneys and colon cancer runs in both directions. Patients with chronic kidney disease appear to face a higher risk of developing colorectal cancer in the first place. The proposed explanations involve the immune suppression and chronic inflammation that accompany declining kidney function. Advanced kidney disease may also damage the intestinal lining in ways that promote malignant changes.25PubMed Central. Association between chronic kidney disease and colorectal cancer: evidence from meta-analysis and Mendelian randomization
This bidirectional relationship creates a compounding problem. A patient who develops colorectal cancer in the setting of existing kidney disease starts treatment at a disadvantage: they are more vulnerable to the kidney-damaging effects of surgery, chemotherapy, and contrast imaging. Research has found that patients with severe pre-existing chronic kidney disease who undergo colorectal cancer treatment face roughly 2.4 times the risk of heart toxicity from their anticancer drugs, compared to those with normal kidney function.26PubMed Central. Pre-existing chronic kidney disease and hypertension increased the risk of cardiotoxicity among colorectal cancer patients treated with anticancer drugs The kidneys and the heart are closely linked physiologically, and stressing one stresses the other.
Monitoring Kidney Function During and After Treatment
Given all these pathways, kidney function monitoring is a routine part of colorectal cancer care. A standard blood test measuring creatinine, a waste product filtered by the kidneys, is the most common tool. But creatinine is an imperfect marker in cancer patients. A Korean study found that interpreting creatinine in isolation can be misleading because muscle mass heavily influences creatinine levels. Patients with low muscle mass and low creatinine actually had worse five-year survival than those with high muscle mass and low creatinine, suggesting that an apparently “normal” creatinine in a frail patient can mask underlying problems.27Annals of Clinical Nutrition and Metabolism. Prognostic significance of serum creatinine and sarcopenia for 5-year overall survival in patients with colorectal cancer in Korea: a comparative study
For patients with pre-existing kidney issues or those receiving nephrotoxic treatments, more frequent lab checks, urine protein testing, and imaging for obstruction are all part of the toolkit. Some treatment protocols now include pre-hydration before contrast scans and proactive electrolyte management around surgery and chemotherapy cycles. If an ileostomy is planned, patients benefit from clear guidance on fluid intake targets and early warning signs of dehydration. The evidence supports that proper preoperative preparation can reduce the incidence of surgery-related kidney injury.28PubMed Central. Acute kidney injury prevalence in patients with colorectal cancer undergoing surgery with curative intent
Cancer care has become increasingly collaborative between oncologists and nephrologists, particularly for patients whose kidney function is borderline before treatment begins. The field of onco-nephrology has emerged precisely because the overlap between cancer and kidney disease is more complex than either specialty can manage alone. For someone navigating colorectal cancer treatment, understanding that kidney problems are a real but largely manageable risk is more useful than being blindsided by a creatinine spike nobody warned you about.